Equity Overview
Price & Market Data
Price: $0.20
Daily Change: -$0.005 / 2.50%
Daily Range: $0.186 - $0.21
Market Cap: $26,774,154
Daily Volume: 1,180,776
Performance Metrics
1 Week: -16.03%
1 Month: -32.25%
3 Months: -43.57%
6 Months: -70.08%
1 Year: -65.73%
YTD: -22.73%
Company Details
Employees: 85
Sector: Health technology
Industry: Medical specialties
Country:
Details
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.